Walgreens Boots Alliance (NASDAQ:WBA) posted its earnings results on Thursday. The pharmacy operator reported $1.17 earnings per share for the quarter, topping the consensus estimate of $1.02 by $0.15, RTT News reports. The firm had revenue of $34.26 billion during the quarter, compared to analysts’ expectations of $33.39 billion. Walgreens Boots Alliance had a return on equity of 20.79% and a net margin of 1.66%. The firm’s revenue was up 12.8% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.02 earnings per share.
NASDAQ:WBA opened at $47.26 on Thursday. The company has a market cap of $40.88 billion, a PE ratio of 17.90, a P/E/G ratio of 1.41 and a beta of 0.49. Walgreens Boots Alliance has a 52 week low of $33.36 and a 52 week high of $57.05. The company has a quick ratio of 0.53, a current ratio of 0.77 and a debt-to-equity ratio of 0.34. The business’s 50 day moving average is $48.70 and its two-hundred day moving average is $50.83.
Several research firms have commented on WBA. TheStreet raised Walgreens Boots Alliance from a “c+” rating to a “b-” rating in a research report on Monday, October 4th. Truist dropped their price objective on Walgreens Boots Alliance from $58.00 to $52.00 and set a “hold” rating on the stock in a report on Friday, July 2nd. Evercore ISI reiterated a “hold” rating and set a $52.00 target price on shares of Walgreens Boots Alliance in a research report on Friday, July 2nd. Deutsche Bank Aktiengesellschaft reduced their price objective on Walgreens Boots Alliance from $55.00 to $52.00 and set a “hold” rating on the stock in a research report on Friday, July 2nd. Finally, Truist Securities dropped their target price on Walgreens Boots Alliance from $58.00 to $52.00 and set a “hold” rating for the company in a research note on Friday, July 2nd. Twelve investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat, Walgreens Boots Alliance currently has an average rating of “Hold” and a consensus price target of $52.81.
Walgreens Boots Alliance, Inc engages in the provision of drug store services. It operates through the following segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment consists of the Walgreens business, which includes the operation of retail drugstores, health and wellness services, and mail and central specialty pharmacy services.
Further Reading: What are popular green investing opportunities?
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.